

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.92073219 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.92073219 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.67030433 |
| 4 | valine metabolic process (GO:0006573) | 4.66635281 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.66411775 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.58834653 |
| 7 | negative regulation of cell killing (GO:0031342) | 4.58834653 |
| 8 | detection of bacterium (GO:0016045) | 4.47060339 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.36029353 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.36029353 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.36029353 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.36029353 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.36029353 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.36029353 |
| 15 | detection of other organism (GO:0098543) | 4.31030454 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.23687685 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.20615401 |
| 18 | low-density lipoprotein particle clearance (GO:0034383) | 4.09175890 |
| 19 | fatty acid transmembrane transport (GO:1902001) | 4.03380853 |
| 20 | B cell receptor signaling pathway (GO:0050853) | 4.02803233 |
| 21 | carnitine shuttle (GO:0006853) | 4.00876575 |
| 22 | regulation of sequestering of triglyceride (GO:0010889) | 4.00399568 |
| 23 | positive regulation of histone deacetylation (GO:0031065) | 3.99427941 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.90339590 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 3.75442288 |
| 26 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.61187222 |
| 27 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.57403015 |
| 28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.54106475 |
| 29 | regulation of cholesterol storage (GO:0010885) | 3.53054967 |
| 30 | germinal center formation (GO:0002467) | 3.51238624 |
| 31 | 2-oxoglutarate metabolic process (GO:0006103) | 3.49730212 |
| 32 | positive thymic T cell selection (GO:0045059) | 3.44357133 |
| 33 | response to muramyl dipeptide (GO:0032495) | 3.43868213 |
| 34 | negative regulation of necroptotic process (GO:0060546) | 3.43605141 |
| 35 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.41829161 |
| 36 | regulation of necroptotic process (GO:0060544) | 3.38633231 |
| 37 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.35390663 |
| 38 | macrophage activation involved in immune response (GO:0002281) | 3.32899503 |
| 39 | regulation of fatty acid oxidation (GO:0046320) | 3.32381908 |
| 40 | detection of external biotic stimulus (GO:0098581) | 3.28973405 |
| 41 | tricarboxylic acid metabolic process (GO:0072350) | 3.25526315 |
| 42 | response to type I interferon (GO:0034340) | 3.23002297 |
| 43 | negative regulation of phagocytosis (GO:0050765) | 3.22652921 |
| 44 | type I interferon signaling pathway (GO:0060337) | 3.21471643 |
| 45 | cellular response to type I interferon (GO:0071357) | 3.21471643 |
| 46 | oxaloacetate metabolic process (GO:0006107) | 3.20200423 |
| 47 | NIK/NF-kappaB signaling (GO:0038061) | 3.18922138 |
| 48 | B cell homeostasis (GO:0001782) | 3.18101206 |
| 49 | positive regulation of fatty acid oxidation (GO:0046321) | 3.16651382 |
| 50 | immunoglobulin mediated immune response (GO:0016064) | 3.16074869 |
| 51 | fatty acid beta-oxidation (GO:0006635) | 3.14353113 |
| 52 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.14351183 |
| 53 | response to peptidoglycan (GO:0032494) | 3.13225971 |
| 54 | carnitine transmembrane transport (GO:1902603) | 3.13178314 |
| 55 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.12698437 |
| 56 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.07494915 |
| 57 | biotin metabolic process (GO:0006768) | 3.04483296 |
| 58 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.03177215 |
| 59 | lysine catabolic process (GO:0006554) | 3.02139775 |
| 60 | lysine metabolic process (GO:0006553) | 3.02139775 |
| 61 | growth hormone receptor signaling pathway (GO:0060396) | 3.01436159 |
| 62 | positive regulation of protein deacetylation (GO:0090312) | 3.01154504 |
| 63 | alpha-linolenic acid metabolic process (GO:0036109) | 3.00243940 |
| 64 | pentose-phosphate shunt (GO:0006098) | 2.99915219 |
| 65 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.99050523 |
| 66 | positive regulation of lipid storage (GO:0010884) | 2.99019499 |
| 67 | carnitine transport (GO:0015879) | 2.95749114 |
| 68 | amino-acid betaine transport (GO:0015838) | 2.95749114 |
| 69 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.95462675 |
| 70 | response to host immune response (GO:0052572) | 2.92163931 |
| 71 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.92163931 |
| 72 | response to host (GO:0075136) | 2.90530131 |
| 73 | response to host defenses (GO:0052200) | 2.90530131 |
| 74 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.90530131 |
| 75 | response to interleukin-15 (GO:0070672) | 2.87223485 |
| 76 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.86738480 |
| 77 | acetyl-CoA metabolic process (GO:0006084) | 2.86599649 |
| 78 | thymic T cell selection (GO:0045061) | 2.85638444 |
| 79 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.84700337 |
| 80 | regulation of triglyceride catabolic process (GO:0010896) | 2.83271922 |
| 81 | negative regulation of granulocyte differentiation (GO:0030853) | 2.83265078 |
| 82 | triglyceride catabolic process (GO:0019433) | 2.82498218 |
| 83 | fatty acid oxidation (GO:0019395) | 2.82207847 |
| 84 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.82178956 |
| 85 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.80619314 |
| 86 | leukocyte aggregation (GO:0070486) | 2.79106480 |
| 87 | detection of biotic stimulus (GO:0009595) | 2.78715398 |
| 88 | mannose metabolic process (GO:0006013) | 2.75193193 |
| 89 | lipid oxidation (GO:0034440) | 2.73907348 |
| 90 | regulation of necrotic cell death (GO:0010939) | 2.73861007 |
| 91 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.72784804 |
| 92 | activation of MAPKKK activity (GO:0000185) | 2.69621593 |
| 93 | lymphocyte homeostasis (GO:0002260) | 2.69312163 |
| 94 | regulation of B cell differentiation (GO:0045577) | 2.68515747 |
| 95 | regulation of cholesterol homeostasis (GO:2000188) | 2.67983912 |
| 96 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.67969457 |
| 97 | NADPH regeneration (GO:0006740) | 2.67466935 |
| 98 | positive regulation of B cell differentiation (GO:0045579) | 2.64396800 |
| 99 | modulation by symbiont of host cellular process (GO:0044068) | 2.63570580 |
| 100 | positive regulation of lipid catabolic process (GO:0050996) | 2.62699474 |
| 101 | histone H3-K36 demethylation (GO:0070544) | 2.62290971 |
| 102 | negative regulation of necrotic cell death (GO:0060547) | 2.61195373 |
| 103 | muscle filament sliding (GO:0030049) | 2.61073828 |
| 104 | actin-myosin filament sliding (GO:0033275) | 2.61073828 |
| 105 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.60383890 |
| 106 | maternal placenta development (GO:0001893) | 2.59854079 |
| 107 | brown fat cell differentiation (GO:0050873) | 2.58691214 |
| 108 | complement activation, alternative pathway (GO:0006957) | 2.58404036 |
| 109 | positive regulation of Rap GTPase activity (GO:0032854) | 2.58257668 |
| 110 | T cell migration (GO:0072678) | 2.58009460 |
| 111 | fatty acid catabolic process (GO:0009062) | 2.57798302 |
| 112 | branched-chain amino acid metabolic process (GO:0009081) | 2.57458193 |
| 113 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.57455230 |
| 114 | natural killer cell differentiation (GO:0001779) | 2.57046865 |
| 115 | cellular response to growth hormone stimulus (GO:0071378) | 2.56552724 |
| 116 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.55287752 |
| 117 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.55259001 |
| 118 | neutral lipid catabolic process (GO:0046461) | 2.51651237 |
| 119 | acylglycerol catabolic process (GO:0046464) | 2.51651237 |
| 120 | positive regulation of interferon-alpha production (GO:0032727) | 2.51174829 |
| 121 | negative regulation of cell size (GO:0045792) | 2.51141138 |
| 122 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.51038202 |
| 123 | cellular response to zinc ion (GO:0071294) | 2.50813369 |
| 124 | fatty acid homeostasis (GO:0055089) | 2.50428938 |
| 125 | regulation of response to interferon-gamma (GO:0060330) | 2.50105402 |
| 126 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.49707593 |
| 127 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.49292692 |
| 128 | negative thymic T cell selection (GO:0045060) | 2.49265753 |
| 129 | negative regulation of innate immune response (GO:0045824) | 2.49101269 |
| 130 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.48905302 |
| 131 | negative regulation of T cell mediated immunity (GO:0002710) | 2.48804302 |
| 132 | negative T cell selection (GO:0043383) | 2.47721405 |
| 133 | T-helper 1 type immune response (GO:0042088) | 2.47680643 |
| 134 | myeloid dendritic cell differentiation (GO:0043011) | 2.46813784 |
| 135 | protein localization to endosome (GO:0036010) | 2.46128302 |
| 136 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.45878968 |
| 137 | cellular response to virus (GO:0098586) | 2.45145215 |
| 138 | modulation by virus of host process (GO:0019054) | 2.44897226 |
| 139 | defense response to protozoan (GO:0042832) | 2.44025497 |
| 140 | white fat cell differentiation (GO:0050872) | 2.43813249 |
| 141 | respiratory burst (GO:0045730) | 2.42786637 |
| 142 | cellular extravasation (GO:0045123) | 2.42106841 |
| 143 | neutrophil activation involved in immune response (GO:0002283) | 2.42090684 |
| 144 | tolerance induction (GO:0002507) | 2.41881261 |
| 145 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.41721914 |
| 146 | positive T cell selection (GO:0043368) | 2.41702229 |
| 147 | regulation of triglyceride metabolic process (GO:0090207) | 2.40357279 |
| 148 | plasma lipoprotein particle clearance (GO:0034381) | 2.40149964 |
| 149 | T cell selection (GO:0045058) | 2.40042573 |
| 150 | intracellular lipid transport (GO:0032365) | 2.39933035 |
| 151 | megakaryocyte development (GO:0035855) | 2.39783183 |
| 152 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.38831068 |
| 153 | embryonic process involved in female pregnancy (GO:0060136) | 2.38788468 |
| 154 | response to laminar fluid shear stress (GO:0034616) | 2.37802567 |
| 155 | ethanol oxidation (GO:0006069) | 2.36990945 |
| 156 | focal adhesion assembly (GO:0048041) | 2.36168798 |
| 157 | cell-substrate adherens junction assembly (GO:0007045) | 2.36168798 |
| 158 | lipid particle organization (GO:0034389) | 2.35818579 |
| 159 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.35721559 |
| 160 | lipid storage (GO:0019915) | 2.35416177 |
| 161 | sarcomere organization (GO:0045214) | 2.35235282 |
| 162 | detection of molecule of bacterial origin (GO:0032490) | 2.35087289 |
| 163 | carnitine metabolic process (GO:0009437) | 2.35010926 |
| 164 | phospholipid homeostasis (GO:0055091) | 2.34716948 |
| 165 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.34176317 |
| 166 | negative regulation of heart growth (GO:0061117) | 2.34176317 |
| 167 | creatine metabolic process (GO:0006600) | 2.33237238 |
| 168 | tricarboxylic acid cycle (GO:0006099) | 2.33054752 |
| 169 | morphogenesis of an endothelium (GO:0003159) | 2.31524782 |
| 170 | endothelial tube morphogenesis (GO:0061154) | 2.31524782 |
| 171 | quaternary ammonium group transport (GO:0015697) | 2.31405516 |
| 172 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.30362557 |
| 173 | skeletal muscle adaptation (GO:0043501) | 2.29691409 |
| 174 | NADH metabolic process (GO:0006734) | 2.26923448 |
| 175 | cellular hyperosmotic response (GO:0071474) | 2.26152557 |
| 176 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.24998961 |
| 177 | Peyers patch development (GO:0048541) | 2.24998961 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.18968489 |
| 2 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.47586294 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.19440261 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.07521925 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.70074215 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.60537956 |
| 7 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.60084644 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.56907476 |
| 9 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.55991365 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.53434394 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.35902255 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.35584567 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.33837679 |
| 14 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.27852791 |
| 15 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.15368763 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.14064594 |
| 17 | * MAF_26560356_Chip-Seq_TH1_Human | 2.11740356 |
| 18 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.08274069 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.02743854 |
| 20 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.96086592 |
| 21 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95653915 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87013356 |
| 23 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.85779715 |
| 24 | UTX_26944678_Chip-Seq_JUKART_Human | 1.84984512 |
| 25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.83744657 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.82352575 |
| 27 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.79566528 |
| 28 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.77495263 |
| 29 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.75604961 |
| 30 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.75520435 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.74130474 |
| 32 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 1.71185958 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.68548949 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.66539938 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.66162874 |
| 36 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.64522503 |
| 37 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.64431982 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.63573398 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.63129328 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62009530 |
| 41 | MYB_26560356_Chip-Seq_TH2_Human | 1.58741692 |
| 42 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.58063147 |
| 43 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.56506605 |
| 44 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.53959031 |
| 45 | * MYB_26560356_Chip-Seq_TH1_Human | 1.53006126 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.52429674 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.51969223 |
| 48 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49447018 |
| 49 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.46051918 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.45100133 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43635585 |
| 52 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.43576739 |
| 53 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43460415 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.39941154 |
| 55 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.38297469 |
| 56 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.38293735 |
| 57 | KDM2B_26808549_Chip-Seq_K562_Human | 1.38020100 |
| 58 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.37569278 |
| 59 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.37144642 |
| 60 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.36893762 |
| 61 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.35970362 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.34011696 |
| 63 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.33594497 |
| 64 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.32330312 |
| 65 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.30570304 |
| 66 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.27009424 |
| 67 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.26653451 |
| 68 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25986240 |
| 69 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.25952668 |
| 70 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.23987639 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22650655 |
| 72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21362455 |
| 73 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.21148856 |
| 74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20575736 |
| 75 | ATF3_27146783_Chip-Seq_COLON_Human | 1.20523075 |
| 76 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.19978188 |
| 77 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.19171429 |
| 78 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.18782534 |
| 79 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.18733582 |
| 80 | GATA1_19941826_ChIP-Seq_K562_Human | 1.18598373 |
| 81 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18515298 |
| 82 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18135998 |
| 83 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.17141983 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.17115286 |
| 85 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.16948307 |
| 86 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.16948307 |
| 87 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.15446920 |
| 88 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.14853728 |
| 89 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14352419 |
| 90 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.13471160 |
| 91 | SPI1_23127762_ChIP-Seq_K562_Human | 1.12753259 |
| 92 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.10654955 |
| 93 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09986384 |
| 94 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09944941 |
| 95 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07793009 |
| 96 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.07761723 |
| 97 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07096213 |
| 98 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07037117 |
| 99 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.07030667 |
| 100 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.06818902 |
| 101 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05555655 |
| 102 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04579756 |
| 103 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04079656 |
| 104 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04035199 |
| 105 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03995026 |
| 106 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.02999285 |
| 107 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.02477211 |
| 108 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02288741 |
| 109 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02258473 |
| 110 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02118774 |
| 111 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.00316926 |
| 112 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.99181551 |
| 113 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98469395 |
| 114 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.98057364 |
| 115 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98038316 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96003151 |
| 117 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95659955 |
| 118 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 0.93673812 |
| 119 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93172423 |
| 120 | * P68_20966046_ChIP-Seq_HELA_Human | 0.91068127 |
| 121 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.90718916 |
| 122 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.90695512 |
| 123 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.89691240 |
| 124 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89285649 |
| 125 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86097344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 3.66384665 |
| 2 | MP0005670_abnormal_white_adipose | 2.93903174 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 2.60874561 |
| 4 | MP0005666_abnormal_adipose_tissue | 2.43259458 |
| 5 | MP0004185_abnormal_adipocyte_glucose | 2.41503626 |
| 6 | MP0004130_abnormal_muscle_cell | 2.40101042 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 2.21246291 |
| 8 | MP0000685_abnormal_immune_system | 2.11160294 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.04380200 |
| 10 | MP0008260_abnormal_autophagy | 2.00576711 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.00239904 |
| 12 | MP0005360_urolithiasis | 1.92596757 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 1.90147594 |
| 14 | MP0001835_abnormal_antigen_presentation | 1.80950108 |
| 15 | MP0002166_altered_tumor_susceptibility | 1.78130982 |
| 16 | MP0005375_adipose_tissue_phenotype | 1.73532620 |
| 17 | MP0003436_decreased_susceptibility_to | 1.71018596 |
| 18 | MP0010329_abnormal_lipoprotein_level | 1.69377364 |
| 19 | MP0003646_muscle_fatigue | 1.68043947 |
| 20 | MP0003566_abnormal_cell_adhesion | 1.67708486 |
| 21 | MP0001790_abnormal_immune_system | 1.66409289 |
| 22 | MP0005387_immune_system_phenotype | 1.66409289 |
| 23 | MP0009840_abnormal_foam_cell | 1.65170833 |
| 24 | MP0001800_abnormal_humoral_immune | 1.63176772 |
| 25 | MP0003763_abnormal_thymus_physiology | 1.56794015 |
| 26 | MP0003303_peritoneal_inflammation | 1.53183868 |
| 27 | MP0004381_abnormal_hair_follicle | 1.50809273 |
| 28 | MP0002971_abnormal_brown_adipose | 1.48704802 |
| 29 | MP0005365_abnormal_bile_salt | 1.47806128 |
| 30 | MP0002396_abnormal_hematopoietic_system | 1.47782894 |
| 31 | MP0000609_abnormal_liver_physiology | 1.47483064 |
| 32 | MP0010352_gastrointestinal_tract_polyps | 1.45382895 |
| 33 | MP0004087_abnormal_muscle_fiber | 1.44281982 |
| 34 | MP0009278_abnormal_bone_marrow | 1.32784968 |
| 35 | MP0005083_abnormal_biliary_tract | 1.32487661 |
| 36 | MP0000751_myopathy | 1.31260440 |
| 37 | MP0008438_abnormal_cutaneous_collagen | 1.30763227 |
| 38 | MP0004084_abnormal_cardiac_muscle | 1.29822796 |
| 39 | MP0001545_abnormal_hematopoietic_system | 1.29360383 |
| 40 | MP0005397_hematopoietic_system_phenotyp | 1.29360383 |
| 41 | MP0002452_abnormal_antigen_presenting | 1.28136470 |
| 42 | MP0004947_skin_inflammation | 1.27177498 |
| 43 | MP0010630_abnormal_cardiac_muscle | 1.27104466 |
| 44 | MP0000858_altered_metastatic_potential | 1.26710407 |
| 45 | MP0005330_cardiomyopathy | 1.24976059 |
| 46 | MP0004808_abnormal_hematopoietic_stem | 1.24896754 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.24720333 |
| 48 | MP0001853_heart_inflammation | 1.24637988 |
| 49 | MP0002398_abnormal_bone_marrow | 1.24422991 |
| 50 | MP0008961_abnormal_basal_metabolism | 1.24147302 |
| 51 | MP0009115_abnormal_fat_cell | 1.22344871 |
| 52 | MP0002138_abnormal_hepatobiliary_system | 1.22232140 |
| 53 | MP0004510_myositis | 1.21313133 |
| 54 | MP0003045_fibrosis | 1.20954246 |
| 55 | MP0003828_pulmonary_edema | 1.20023166 |
| 56 | MP0005310_abnormal_salivary_gland | 1.18866161 |
| 57 | MP0005076_abnormal_cell_differentiation | 1.18634739 |
| 58 | MP0000750_abnormal_muscle_regeneration | 1.18165913 |
| 59 | MP0002420_abnormal_adaptive_immunity | 1.17576866 |
| 60 | MP0000749_muscle_degeneration | 1.17040842 |
| 61 | MP0002148_abnormal_hypersensitivity_rea | 1.17021477 |
| 62 | MP0000733_abnormal_muscle_development | 1.16833550 |
| 63 | MP0005000_abnormal_immune_tolerance | 1.16653853 |
| 64 | MP0005085_abnormal_gallbladder_physiolo | 1.16114280 |
| 65 | MP0001819_abnormal_immune_cell | 1.15652953 |
| 66 | MP0001533_abnormal_skeleton_physiology | 1.15191318 |
| 67 | MP0000689_abnormal_spleen_morphology | 1.14893619 |
| 68 | MP0005025_abnormal_response_to | 1.13816790 |
| 69 | MP0002723_abnormal_immune_serum | 1.13804038 |
| 70 | MP0004264_abnormal_extraembryonic_tissu | 1.13467526 |
| 71 | MP0010155_abnormal_intestine_physiology | 1.13321409 |
| 72 | MP0002006_tumorigenesis | 1.13091707 |
| 73 | MP0002722_abnormal_immune_system | 1.12192843 |
| 74 | MP0005275_abnormal_skin_tensile | 1.12034460 |
| 75 | MP0000490_abnormal_crypts_of | 1.10490289 |
| 76 | MP0002009_preneoplasia | 1.10454356 |
| 77 | MP0005501_abnormal_skin_physiology | 1.10271358 |
| 78 | MP0003091_abnormal_cell_migration | 1.10229525 |
| 79 | MP0003183_abnormal_peptide_metabolism | 1.08812267 |
| 80 | MP0004036_abnormal_muscle_relaxation | 1.08804150 |
| 81 | MP0010234_abnormal_vibrissa_follicle | 1.08329982 |
| 82 | MP0001873_stomach_inflammation | 1.08306105 |
| 83 | MP0000716_abnormal_immune_system | 1.06045007 |
| 84 | MP0003252_abnormal_bile_duct | 1.05472287 |
| 85 | MP0002118_abnormal_lipid_homeostasis | 1.05232785 |
| 86 | MP0002405_respiratory_system_inflammati | 1.04545563 |
| 87 | MP0005334_abnormal_fat_pad | 1.04467397 |
| 88 | MP0002970_abnormal_white_adipose | 1.03840696 |
| 89 | MP0004858_abnormal_nervous_system | 1.03729552 |
| 90 | MP0004145_abnormal_muscle_electrophysio | 1.03314814 |
| 91 | MP0000759_abnormal_skeletal_muscle | 1.03122422 |
| 92 | MP0009785_altered_susceptibility_to | 1.02353217 |
| 93 | MP0003866_abnormal_defecation | 1.01904832 |
| 94 | MP0002877_abnormal_melanocyte_morpholog | 1.01745285 |
| 95 | MP0000003_abnormal_adipose_tissue | 1.00955213 |
| 96 | MP0003221_abnormal_cardiomyocyte_apopto | 1.00773280 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 1.00279489 |
| 98 | MP0005385_cardiovascular_system_phenoty | 0.99860744 |
| 99 | MP0001544_abnormal_cardiovascular_syste | 0.99860744 |
| 100 | MP0001851_eye_inflammation | 0.99809963 |
| 101 | MP0005671_abnormal_response_to | 0.97908519 |
| 102 | MP0008875_abnormal_xenobiotic_pharmacok | 0.97794630 |
| 103 | MP0001348_abnormal_lacrimal_gland | 0.97623660 |
| 104 | MP0002106_abnormal_muscle_physiology | 0.96629228 |
| 105 | MP0002429_abnormal_blood_cell | 0.96504601 |
| 106 | MP0002998_abnormal_bone_remodeling | 0.96343063 |
| 107 | MP0000747_muscle_weakness | 0.95014109 |
| 108 | MP0005023_abnormal_wound_healing | 0.94325121 |
| 109 | MP0002132_abnormal_respiratory_system | 0.94170489 |
| 110 | MP0002796_impaired_skin_barrier | 0.93867472 |
| 111 | MP0001845_abnormal_inflammatory_respons | 0.93860293 |
| 112 | MP0002419_abnormal_innate_immunity | 0.93691007 |
| 113 | MP0009333_abnormal_splenocyte_physiolog | 0.93231368 |
| 114 | MP0003656_abnormal_erythrocyte_physiolo | 0.92874032 |
| 115 | MP0004233_abnormal_muscle_weight | 0.92227655 |
| 116 | MP0002254_reproductive_system_inflammat | 0.91917712 |
| 117 | MP0000343_altered_response_to | 0.91709128 |
| 118 | MP0000703_abnormal_thymus_morphology | 0.91666988 |
| 119 | MP0003453_abnormal_keratinocyte_physiol | 0.91488803 |
| 120 | MP0003724_increased_susceptibility_to | 0.90766212 |
| 121 | MP0006036_abnormal_mitochondrial_physio | 0.90448302 |
| 122 | MP0005058_abnormal_lysosome_morphology | 0.90222061 |
| 123 | MP0008469_abnormal_protein_level | 0.89678686 |
| 124 | MP0002269_muscular_atrophy | 0.89162757 |
| 125 | MP0000598_abnormal_liver_morphology | 0.88842508 |
| 126 | MP0003172_abnormal_lysosome_physiology | 0.88169319 |
| 127 | MP0009931_abnormal_skin_appearance | 0.85927245 |
| 128 | MP0005409_darkened_coat_color | 0.83692171 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myoglobinuria (HP:0002913) | 3.59032270 |
| 2 | Increased connective tissue (HP:0009025) | 3.53639366 |
| 3 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.47093777 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 3.38402483 |
| 5 | Hyporeflexia of lower limbs (HP:0002600) | 3.23214807 |
| 6 | Meningitis (HP:0001287) | 3.19663588 |
| 7 | Rhabdomyolysis (HP:0003201) | 3.17688882 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 3.14884567 |
| 9 | Exercise-induced myalgia (HP:0003738) | 3.13782010 |
| 10 | Exercise-induced muscle cramps (HP:0003710) | 3.01624867 |
| 11 | Recurrent abscess formation (HP:0002722) | 2.99372673 |
| 12 | Muscle fiber inclusion bodies (HP:0100299) | 2.99003991 |
| 13 | Difficulty running (HP:0009046) | 2.96514350 |
| 14 | Abnormality of macrophages (HP:0004311) | 2.94418499 |
| 15 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.89023377 |
| 16 | Vasculitis (HP:0002633) | 2.83408543 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 2.82533692 |
| 18 | Distal lower limb muscle weakness (HP:0009053) | 2.81094570 |
| 19 | Muscle fiber splitting (HP:0003555) | 2.79093650 |
| 20 | Verrucae (HP:0200043) | 2.78673529 |
| 21 | Papilloma (HP:0012740) | 2.78673529 |
| 22 | Myocardial infarction (HP:0001658) | 2.73172670 |
| 23 | Gastrointestinal infarctions (HP:0005244) | 2.71976970 |
| 24 | Distal lower limb amyotrophy (HP:0008944) | 2.69831642 |
| 25 | Polycythemia (HP:0001901) | 2.64517334 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.63886323 |
| 27 | Abnormality of the nasal mucosa (HP:0000433) | 2.58703515 |
| 28 | Nemaline bodies (HP:0003798) | 2.56887401 |
| 29 | Deep venous thrombosis (HP:0002625) | 2.56699439 |
| 30 | Recurrent sinusitis (HP:0011108) | 2.56285717 |
| 31 | Ventricular tachycardia (HP:0004756) | 2.55222231 |
| 32 | Autoimmune thrombocytopenia (HP:0001973) | 2.54131450 |
| 33 | Lymphopenia (HP:0001888) | 2.53287929 |
| 34 | Right ventricular cardiomyopathy (HP:0011663) | 2.52030053 |
| 35 | Colitis (HP:0002583) | 2.50851505 |
| 36 | Nasal polyposis (HP:0100582) | 2.47778721 |
| 37 | Urticaria (HP:0001025) | 2.47212898 |
| 38 | Ulnar deviation of the wrist (HP:0003049) | 2.47018598 |
| 39 | Myositis (HP:0100614) | 2.44997250 |
| 40 | Osteomyelitis (HP:0002754) | 2.44553175 |
| 41 | Asymmetric septal hypertrophy (HP:0001670) | 2.43641473 |
| 42 | Spontaneous hematomas (HP:0007420) | 2.43060296 |
| 43 | Cellulitis (HP:0100658) | 2.42027465 |
| 44 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.41758756 |
| 45 | Hypertriglyceridemia (HP:0002155) | 2.41624879 |
| 46 | Complement deficiency (HP:0004431) | 2.40659570 |
| 47 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.40009166 |
| 48 | Cerebral aneurysm (HP:0004944) | 2.39270642 |
| 49 | Orchitis (HP:0100796) | 2.38153911 |
| 50 | Chronic obstructive pulmonary disease (HP:0006510) | 2.34894035 |
| 51 | Obstructive lung disease (HP:0006536) | 2.34894035 |
| 52 | Gastrointestinal inflammation (HP:0004386) | 2.33366431 |
| 53 | Facial diplegia (HP:0001349) | 2.33150155 |
| 54 | Inflammation of the large intestine (HP:0002037) | 2.32906764 |
| 55 | Restrictive lung disease (HP:0002091) | 2.31412235 |
| 56 | Xanthomatosis (HP:0000991) | 2.31371273 |
| 57 | Recurrent viral infections (HP:0004429) | 2.30776376 |
| 58 | Gingivitis (HP:0000230) | 2.27143287 |
| 59 | Abnormal platelet volume (HP:0011876) | 2.25749387 |
| 60 | Hyperglycinuria (HP:0003108) | 2.25366979 |
| 61 | Abnormality of nail color (HP:0100643) | 2.23793805 |
| 62 | Frequent falls (HP:0002359) | 2.23318164 |
| 63 | Abnormality of the fingertips (HP:0001211) | 2.22038315 |
| 64 | Increased IgE level (HP:0003212) | 2.20601578 |
| 65 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.20238080 |
| 66 | Recurrent skin infections (HP:0001581) | 2.19835361 |
| 67 | Chest pain (HP:0100749) | 2.19616066 |
| 68 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.19287904 |
| 69 | Recurrent bronchitis (HP:0002837) | 2.17682460 |
| 70 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.13945397 |
| 71 | Lipoatrophy (HP:0100578) | 2.13322313 |
| 72 | Conjunctival hamartoma (HP:0100780) | 2.13050289 |
| 73 | Hyperammonemia (HP:0001987) | 2.13046441 |
| 74 | Hypochromic anemia (HP:0001931) | 2.12494238 |
| 75 | Eczematoid dermatitis (HP:0000976) | 2.11220596 |
| 76 | Fatigue (HP:0012378) | 2.10519143 |
| 77 | Sudden death (HP:0001699) | 2.10079469 |
| 78 | Easy fatigability (HP:0003388) | 2.09394896 |
| 79 | Increased mean platelet volume (HP:0011877) | 2.09361535 |
| 80 | Hematochezia (HP:0002573) | 2.08296790 |
| 81 | Hypoglycemic coma (HP:0001325) | 2.07199159 |
| 82 | Recurrent fungal infections (HP:0002841) | 2.06457669 |
| 83 | Abnormal platelet function (HP:0011869) | 2.06380845 |
| 84 | Impaired platelet aggregation (HP:0003540) | 2.06380845 |
| 85 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.06166762 |
| 86 | Recurrent cutaneous fungal infections (HP:0011370) | 2.06166762 |
| 87 | Subaortic stenosis (HP:0001682) | 2.05826393 |
| 88 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.05826393 |
| 89 | Ketosis (HP:0001946) | 2.04956451 |
| 90 | Acanthosis nigricans (HP:0000956) | 2.04370321 |
| 91 | IgM deficiency (HP:0002850) | 2.02974323 |
| 92 | Agammaglobulinemia (HP:0004432) | 2.02766758 |
| 93 | Hypertensive crisis (HP:0100735) | 2.01943338 |
| 94 | Abnormality of complement system (HP:0005339) | 2.01429522 |
| 95 | Pustule (HP:0200039) | 2.01403493 |
| 96 | Prolonged bleeding time (HP:0003010) | 2.01306725 |
| 97 | Increased variability in muscle fiber diameter (HP:0003557) | 2.00671329 |
| 98 | Multiple enchondromatosis (HP:0005701) | 1.99929736 |
| 99 | Hypoalphalipoproteinemia (HP:0003233) | 1.99522980 |
| 100 | Chronic otitis media (HP:0000389) | 1.98312068 |
| 101 | Neck muscle weakness (HP:0000467) | 1.97806862 |
| 102 | EMG: myopathic abnormalities (HP:0003458) | 1.97160718 |
| 103 | Increased density of long bones (HP:0006392) | 1.96968481 |
| 104 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.96872042 |
| 105 | Distal arthrogryposis (HP:0005684) | 1.95607841 |
| 106 | Optic neuritis (HP:0100653) | 1.95534760 |
| 107 | Retrobulbar optic neuritis (HP:0100654) | 1.95534760 |
| 108 | Myopathic facies (HP:0002058) | 1.95227973 |
| 109 | Encephalitis (HP:0002383) | 1.94992941 |
| 110 | Calf muscle hypertrophy (HP:0008981) | 1.94106233 |
| 111 | Obstructive sleep apnea (HP:0002870) | 1.93930375 |
| 112 | Difficulty climbing stairs (HP:0003551) | 1.92769784 |
| 113 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.92470814 |
| 114 | Aortic aneurysm (HP:0004942) | 1.92164825 |
| 115 | Round ear (HP:0100830) | 1.92013663 |
| 116 | Viral hepatitis (HP:0006562) | 1.91761705 |
| 117 | Muscle stiffness (HP:0003552) | 1.87379884 |
| 118 | T lymphocytopenia (HP:0005403) | 1.87186732 |
| 119 | Panhypogammaglobulinemia (HP:0003139) | 1.86579165 |
| 120 | Hemorrhage of the eye (HP:0011885) | 1.86424922 |
| 121 | Skin ulcer (HP:0200042) | 1.86192272 |
| 122 | Reticulocytosis (HP:0001923) | 1.84559603 |
| 123 | Slender build (HP:0001533) | 1.84551778 |
| 124 | Esophageal varix (HP:0002040) | 1.84190100 |
| 125 | Abnormality of glycine metabolism (HP:0010895) | 1.84183684 |
| 126 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.84183684 |
| 127 | Bulbar palsy (HP:0001283) | 1.83685576 |
| 128 | Sepsis (HP:0100806) | 1.82825905 |
| 129 | Hyperlipoproteinemia (HP:0010980) | 1.82550711 |
| 130 | Pulmonary infiltrates (HP:0002113) | 1.82181638 |
| 131 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.81966357 |
| 132 | Keratoconjunctivitis sicca (HP:0001097) | 1.81837947 |
| 133 | Abnormality of T cell number (HP:0011839) | 1.80050840 |
| 134 | Abnormality of T cell physiology (HP:0011840) | 1.79955439 |
| 135 | Abnormal gallbladder physiology (HP:0012438) | 1.79824664 |
| 136 | Cholecystitis (HP:0001082) | 1.79824664 |
| 137 | Gastrointestinal stroma tumor (HP:0100723) | 1.78707512 |
| 138 | Skin rash (HP:0000988) | 1.77966747 |
| 139 | Abnormality of T cells (HP:0002843) | 1.77708800 |
| 140 | Slow saccadic eye movements (HP:0000514) | 1.77092946 |
| 141 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.75938051 |
| 142 | Interstitial pulmonary disease (HP:0006530) | 1.75842906 |
| 143 | Emphysema (HP:0002097) | 1.75173432 |
| 144 | Spastic diplegia (HP:0001264) | 1.73540143 |
| 145 | Aneurysm (HP:0002617) | 1.73500689 |
| 146 | Malnutrition (HP:0004395) | 1.73365180 |
| 147 | Recurrent lower respiratory tract infections (HP:0002783) | 1.72273290 |
| 148 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.72210966 |
| 149 | Oligomenorrhea (HP:0000876) | 1.71846738 |
| 150 | IgA deficiency (HP:0002720) | 1.71722020 |
| 151 | Thrombocytosis (HP:0001894) | 1.71051741 |
| 152 | Ketoacidosis (HP:0001993) | 1.70954820 |
| 153 | Epistaxis (HP:0000421) | 1.70433488 |
| 154 | Rectal prolapse (HP:0002035) | 1.70344466 |
| 155 | Atrioventricular block (HP:0001678) | 1.68852603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.03182432 |
| 2 | PRPF4B | 4.39816426 |
| 3 | PKN2 | 3.64504472 |
| 4 | EEF2K | 3.44598060 |
| 5 | MAP4K1 | 3.31682050 |
| 6 | RIPK4 | 3.21685998 |
| 7 | MAP3K10 | 2.95535025 |
| 8 | TTN | 2.85571650 |
| 9 | ERN1 | 2.81585980 |
| 10 | SMG1 | 2.71697582 |
| 11 | SIK1 | 2.10616603 |
| 12 | MAP2K3 | 2.03507653 |
| 13 | FGFR4 | 1.97694657 |
| 14 | IRAK4 | 1.97416457 |
| 15 | MAP3K13 | 1.94655913 |
| 16 | JAK3 | 1.78645952 |
| 17 | BCKDK | 1.77591561 |
| 18 | LRRK2 | 1.76668766 |
| 19 | TYK2 | 1.74472774 |
| 20 | CAMK1D | 1.72871011 |
| 21 | STK10 | 1.69470047 |
| 22 | PTK6 | 1.57560181 |
| 23 | RIPK1 | 1.56973187 |
| 24 | GRK6 | 1.52250297 |
| 25 | TGFBR2 | 1.50320432 |
| 26 | CDK12 | 1.49112677 |
| 27 | EPHB1 | 1.46881047 |
| 28 | JAK1 | 1.43354765 |
| 29 | TAOK2 | 1.38244731 |
| 30 | ZAP70 | 1.35272134 |
| 31 | FGFR3 | 1.31513852 |
| 32 | FLT3 | 1.30457509 |
| 33 | TNK2 | 1.26973537 |
| 34 | OBSCN | 1.25224370 |
| 35 | TBK1 | 1.22944524 |
| 36 | MAP3K7 | 1.22415370 |
| 37 | MAP3K1 | 1.17716360 |
| 38 | KSR2 | 1.16306972 |
| 39 | MARK2 | 1.14427139 |
| 40 | CAMK1G | 1.14035698 |
| 41 | BTK | 1.11755405 |
| 42 | SIK3 | 1.05230299 |
| 43 | CDK4 | 1.02234312 |
| 44 | PRKD2 | 1.01453262 |
| 45 | CDK6 | 1.00689799 |
| 46 | CDC42BPA | 0.99600140 |
| 47 | ITK | 0.98589741 |
| 48 | MAP3K3 | 0.98542802 |
| 49 | PDK3 | 0.93021117 |
| 50 | PDK4 | 0.93021117 |
| 51 | CSF1R | 0.92412521 |
| 52 | DMPK | 0.91576200 |
| 53 | PDPK1 | 0.88357552 |
| 54 | CSK | 0.87392462 |
| 55 | JAK2 | 0.86586247 |
| 56 | NEK9 | 0.86436063 |
| 57 | MAP3K14 | 0.85758137 |
| 58 | PIM1 | 0.85168961 |
| 59 | MAPK11 | 0.84634800 |
| 60 | HIPK2 | 0.84525486 |
| 61 | MST1R | 0.81895387 |
| 62 | BMX | 0.81858289 |
| 63 | IKBKE | 0.81712604 |
| 64 | MAPKAPK3 | 0.79385757 |
| 65 | RPS6KB2 | 0.79326731 |
| 66 | PRKAA2 | 0.76843898 |
| 67 | SYK | 0.76284983 |
| 68 | RPS6KA4 | 0.76067780 |
| 69 | HCK | 0.75566032 |
| 70 | KDR | 0.75347293 |
| 71 | TRPM7 | 0.74575417 |
| 72 | PDGFRA | 0.74411806 |
| 73 | STK4 | 0.73412519 |
| 74 | TIE1 | 0.73020838 |
| 75 | MTOR | 0.72984498 |
| 76 | CHUK | 0.70848138 |
| 77 | MAPK7 | 0.70559113 |
| 78 | CDK9 | 0.70247300 |
| 79 | MAPK12 | 0.66960223 |
| 80 | SGK3 | 0.66630067 |
| 81 | ILK | 0.66592209 |
| 82 | NEK2 | 0.65755020 |
| 83 | MARK3 | 0.64173306 |
| 84 | IKBKB | 0.63736225 |
| 85 | LYN | 0.63196889 |
| 86 | FES | 0.62996815 |
| 87 | FGR | 0.62213131 |
| 88 | EPHA3 | 0.61211695 |
| 89 | IRAK2 | 0.61103076 |
| 90 | PIK3CG | 0.59683983 |
| 91 | BLK | 0.59662820 |
| 92 | TAOK1 | 0.59621453 |
| 93 | ARAF | 0.58735300 |
| 94 | MAP3K8 | 0.58392133 |
| 95 | PRKCH | 0.58214357 |
| 96 | KIT | 0.58129803 |
| 97 | LCK | 0.57244573 |
| 98 | RPS6KA2 | 0.57163254 |
| 99 | IRAK1 | 0.57002622 |
| 100 | MAP3K11 | 0.56998926 |
| 101 | TGFBR1 | 0.56843441 |
| 102 | SIK2 | 0.55761874 |
| 103 | LMTK2 | 0.55435723 |
| 104 | DYRK1B | 0.55320794 |
| 105 | PAK4 | 0.54406695 |
| 106 | MAP3K9 | 0.53882774 |
| 107 | EPHA2 | 0.53779222 |
| 108 | MAP2K2 | 0.53347553 |
| 109 | ICK | 0.50830088 |
| 110 | MAP3K6 | 0.49751010 |
| 111 | PRKD1 | 0.49497742 |
| 112 | NME2 | 0.48491962 |
| 113 | PDK1 | 0.48216234 |
| 114 | MAPK4 | 0.47239637 |
| 115 | STK24 | 0.47026251 |
| 116 | NLK | 0.45826299 |
| 117 | IRAK3 | 0.45675206 |
| 118 | STK3 | 0.45282239 |
| 119 | ALK | 0.45255388 |
| 120 | PASK | 0.44415228 |
| 121 | RPS6KA6 | 0.43691593 |
| 122 | RET | 0.43477515 |
| 123 | PDGFRB | 0.42769970 |
| 124 | TAOK3 | 0.42348426 |
| 125 | TEC | 0.41328849 |
| 126 | RPS6KL1 | 0.41211052 |
| 127 | RPS6KC1 | 0.41211052 |
| 128 | MAPKAPK2 | 0.40584510 |
| 129 | TXK | 0.40441016 |
| 130 | CLK1 | 0.40075669 |
| 131 | RPS6KA1 | 0.39931017 |
| 132 | BRAF | 0.39502203 |
| 133 | YES1 | 0.36835113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.61366740 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.57959642 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.53108712 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.49353493 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.47401404 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.35736395 |
| 7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.32635512 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.31600668 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.23782732 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.21521559 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.12138480 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.07102989 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.97109656 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.93966229 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.68057190 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65339358 |
| 17 | Carbon metabolism_Homo sapiens_hsa01200 | 1.64245018 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.62709825 |
| 19 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.61843236 |
| 20 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.58632066 |
| 21 | Insulin resistance_Homo sapiens_hsa04931 | 1.57157328 |
| 22 | Lysine degradation_Homo sapiens_hsa00310 | 1.51185508 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.49798528 |
| 24 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.42606139 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.40578742 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.39604934 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.36996278 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35738266 |
| 29 | Asthma_Homo sapiens_hsa05310 | 1.34076880 |
| 30 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.32977000 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.32380237 |
| 32 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.30829268 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.27091991 |
| 34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.25704236 |
| 35 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.24692016 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.23719422 |
| 37 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.20710718 |
| 38 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.20640529 |
| 39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.18660917 |
| 40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.18094594 |
| 41 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.16897382 |
| 42 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.16803387 |
| 43 | Leishmaniasis_Homo sapiens_hsa05140 | 1.15938416 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.15126591 |
| 45 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.12506573 |
| 46 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.10920170 |
| 47 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.10827526 |
| 48 | Endometrial cancer_Homo sapiens_hsa05213 | 1.07397593 |
| 49 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.06997572 |
| 50 | Measles_Homo sapiens_hsa05162 | 1.06008645 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.01956307 |
| 52 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.00897889 |
| 53 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.99920505 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99012904 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.97844153 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.97451773 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.96614486 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.96018624 |
| 59 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94057153 |
| 60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.93001871 |
| 61 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.92215234 |
| 62 | Malaria_Homo sapiens_hsa05144 | 0.91636895 |
| 63 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.90793588 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.90491749 |
| 65 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89105382 |
| 66 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.88588744 |
| 67 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.87830108 |
| 68 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86847592 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.86166819 |
| 70 | Peroxisome_Homo sapiens_hsa04146 | 0.85863292 |
| 71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.85399786 |
| 72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.83897233 |
| 73 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.83003318 |
| 74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81998946 |
| 75 | Platelet activation_Homo sapiens_hsa04611 | 0.80883425 |
| 76 | Bladder cancer_Homo sapiens_hsa05219 | 0.80609451 |
| 77 | Thyroid cancer_Homo sapiens_hsa05216 | 0.80381755 |
| 78 | Prostate cancer_Homo sapiens_hsa05215 | 0.80157385 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79255581 |
| 80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.78665588 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78464036 |
| 82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.78452280 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.77677469 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77199301 |
| 85 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.75444734 |
| 86 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.74000785 |
| 87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73275386 |
| 88 | Apoptosis_Homo sapiens_hsa04210 | 0.72822820 |
| 89 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71991954 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.71874605 |
| 91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.70351206 |
| 92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69781509 |
| 93 | Focal adhesion_Homo sapiens_hsa04510 | 0.69318614 |
| 94 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68711154 |
| 95 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68442142 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67184310 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67158160 |
| 98 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.66686131 |
| 99 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.66498070 |
| 100 | Glioma_Homo sapiens_hsa05214 | 0.65419780 |
| 101 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.65332295 |
| 102 | Shigellosis_Homo sapiens_hsa05131 | 0.63632400 |
| 103 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.63251587 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61964404 |
| 105 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.61493257 |
| 106 | Colorectal cancer_Homo sapiens_hsa05210 | 0.61308524 |
| 107 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.61306449 |
| 108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60883765 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60546818 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58908177 |
| 111 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58501581 |
| 112 | Influenza A_Homo sapiens_hsa05164 | 0.58366172 |
| 113 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58280168 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58038679 |
| 115 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57870066 |
| 116 | Hepatitis B_Homo sapiens_hsa05161 | 0.57087188 |
| 117 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56982424 |
| 118 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.56675790 |
| 119 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56361021 |
| 120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.56034304 |
| 121 | Legionellosis_Homo sapiens_hsa05134 | 0.55588869 |
| 122 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55382724 |
| 123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55229518 |
| 124 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55150459 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.53538558 |
| 126 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.50072711 |
| 127 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49419230 |
| 128 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.49178474 |
| 129 | Bile secretion_Homo sapiens_hsa04976 | 0.48478300 |
| 130 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47935258 |
| 131 | Hepatitis C_Homo sapiens_hsa05160 | 0.47675405 |
| 132 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45899018 |
| 133 | Adherens junction_Homo sapiens_hsa04520 | 0.45316089 |
| 134 | Phagosome_Homo sapiens_hsa04145 | 0.45075797 |
| 135 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44441367 |
| 136 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.44366649 |
| 137 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43565196 |
| 138 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.43221596 |
| 139 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43014341 |
| 140 | Prion diseases_Homo sapiens_hsa05020 | 0.42817823 |
| 141 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42624296 |
| 142 | Amoebiasis_Homo sapiens_hsa05146 | 0.42528763 |

